Related Experiment Video
Updated: Mar 9, 2026

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
Glucose transport 1 deficiency presenting as infantile spasms with a mutation identified in exon 9 of SLC2A1
1Department of Pediatrics, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.
Insights
Glucose transporter 1 (GLUT-1) deficiency, a rare genetic disorder, causes severe epilepsy and developmental delays. This case highlights a new mutation in the SLC2A1 gene, emphasizing the need for early diagnosis and genetic testing.
Area of Science:
- Genetics
- Neurology
- Metabolic Disorders
Background:
- Glucose transporter 1 (GLUT-1) deficiency is a rare genetic syndrome.
- It is characterized by early-onset intractable epilepsy, developmental delay, and movement disorders.
- Mutations in the SLC2A1 gene are the underlying cause, with specific hot spots identified.
Purpose of the Study:
- To report a case of GLUT-1 deficiency presenting with infantile spasms and developmental delay.
- To investigate the genetic basis of the condition in this patient.
- To contribute to the understanding of SLC2A1 mutations and their clinical manifestations.
Main Methods:
- Clinical case description including symptoms and developmental milestones.
- Metabolic workup including cerebrospinal fluid (CSF) analysis.
- Bidirectional sequencing of the SLC2A1 gene to identify mutations.
Main Results:
- The patient presented with infantile spasms and delayed development at 6 months of age.
- Intractable epilepsy persisted despite aggressive antiepileptic drug therapy.
- CSF analysis revealed a low CSF-glucose-to-blood-glucose ratio (0.38) with normal lactate.
- SLC2A1 sequencing identified a novel missense mutation (c.1198C>T, p.Arg400Cys) in exon 9.
Conclusions:
- This case illustrates a new SLC2A1 mutation causing GLUT-1 deficiency.
- Early identification of GLUT-1 deficiency is crucial for timely intervention.
- Genetic analysis of SLC2A1 is essential for diagnosing this rare syndrome.
Abstract:
Glucose transport 1 (GLUT-1) deficiency is a rare syndrome caused by mutations in the glucose transporter 1 gene (SLC2A1) and is characterized by early-onset intractable epilepsy, delayed development, and movement disorder. De novo mutations and several hot spots in N34, G91, R126, R153, and R333 of exons 2, 3, 4, and 8 of SLC2A1 are associated with this condition. Seizures, one of the main clinical features of GLUT-1 deficiency, usually develop during infancy. Most patients experience brief and subtle myoclonic jerk and focal seizures that evolve into a mixture of different types of seizures, such as generalized tonic-clonic, absence, myoclonic, and complex partial seizures. Here, we describe the case of a patient with GLUT-1 deficiency who developed infantile spasms and showed delayed development at 6 months of age. She had intractable epilepsy despite receiving aggressive antiepileptic drug therapy, and underwent a metabolic workup. Cerebrospinal fluid (CSF) examination showed CSF-glucose-to-blood-glucose ratio of 0.38, with a normal lactate level. Bidirectional sequencing of SLC2A1 identified a missense mutation (c.1198C>T) at codon 400 (p.Arg400Cys) of exon 9.
More Related Videos
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism
Glucose Absorption Into the Small Intestine
Secondary Active Transport
Secondary Active Transport
Lysosomal Hydrolases

